Compare POET & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
POET Technologies Inc offers integration solutions based on the POET Optical Interposer, a novel platform for the seamless integration of electronic and photonic devices into a single module using wafer-level manufacturing techniques and packaging methods. The company operates in a single segment of design, manufacture, and sale of semiconductor products and services for commercial applications. The products of the company are POET Starlight, POET Lightbar, POET Infinity, POET One, and others. Its products have applications in Data Centers, Telecommunications, the Internet of Things & Industrial Sensing, Automotive LIDAR, and On-Board Optics. Its geographical segments are Asia, the United States, and Canada.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.